← Skyward Specialty Insurance Group, Inc.
| Annual Trend | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|
| Net income | $38.3m |
$39.4m
+2.82%
|
$86.0m
+118.26%
|
$118.8m
+38.20%
|
$170.0m
+43.09%
|
$187.9m
+10.51%
|
|
| Depreciation and amortization expense | $5.6m | $4.1m | $3.9m | $3.4m | $3.5m | $3.5m | |
| Deferred income tax, net | $10.0m | $10.3m | $9.4m | ($8.7m) | ($6.4m) | ($6.4m) | |
| Stock-based compensation expense | $522k | $2.3m | $8.5m | $9.4m | $12.0m | $12.0m | |
| Purchase of equity method investments and other long-term investments | ($16.1m) | ($9.8m) | $0 | ($32.2m) | ($6.8m) | — | |
| Sales of and distributions from equity method and other long-term investments | — | $3.4m | $3.6m | $14.1m | $11.9m | — | |
| Reinsurance and premium payables | ($4.2m) | ($6.2m) | $36.5m | $26.9m | $102.8m | — | |
| Accounts payable and accrued liabilities | $1.1m | $7.6m | $2.3m | $19.2m | $37.0m | — | |
| Ceded unearned premium | $8.5m | ($19.7m) | ($28.5m) | ($17.8m) | ($35.0m) | — | |
| Unearned premiums | $20.8m | $79.2m | $110.0m | $84.7m | $136.8m | — | |
| Net cash provided by operating activities | $175.3m |
$208.9m
+19.20%
|
$338.2m
+61.86%
|
$305.1m
-9.78%
|
$408.1m
+33.74%
|
$407.3m
-0.19%
|
|
| Purchase of property and equipment | ($2.2m) | ($2.3m) | ($3.1m) | ($4.2m) | ($5.5m) | ($308.2m) | |
| Undistributed earnings (loss) from long-term investments | ($11.4m) | ($16.0m) | $6.7m | ($6.3m) | $10.1m | — | |
| Purchase of illiquid investments | ($48.1m) | ($4.9m) | ($1.7m) | ($75k) | $0 | — | |
| Change in short-term investments | $70.2m | $43.1m | ($149.1m) | ($4.8m) | $10.6m | — | |
| Proceeds from long term borrowings | — | $0 | $50.0m | $107.0m | $43.4m | — | |
| Payments on long term borrowings and trust preferred | — | $0 | ($50.0m) | ($116.8m) | ($43.0m) | — | |
| Net cash provided by (used in) financing activities | $1.4m |
$2.2m
+57.97%
|
$130.9m
+5906.74%
|
($4.2m)
-103.23%
|
$411k
+109.71%
|
$302.3m
+73445.74%
|
|
| Net increase (decrease) in cash and cash equivalents and restricted cash | ($6.3m) | $17.7m | ($24.7m) | $57.2m | $41.6m | — | |
| Cash and cash equivalents and restricted cash at beginning of period | $107.3m | $125.0m | $100.3m | $157.5m | $199.1m | — | |
| Additional Supplementary Disclosures | |||||||
| Additional Supplementary Disclosures | |||||||
| Net investment (gains) losses | ($1.9m) | $647k | ($11.1m) | ($6.3m) | ($22.1m) | — | |
| Net change in fair value of derivatives | — | — | $0 | $0 | ($34.9m) | — | |
| Premiums receivable, net | $1.9m | ($27.7m) | ($40.0m) | ($142.4m) | ($222.6m) | — | |
| Reinsurance recoverables, net | $1.1m | ($45.0m) | ($17.3m) | ($261.5m) | ($262.0m) | — | |
| Deferred policy acquisition costs | ($6.0m) | ($9.5m) | ($23.0m) | ($21.2m) | ($22.9m) | — | |
| Federal income taxes | — | $0 | ($1.9m) | $4.5m | $1.8m | — | |
| Losses and loss adjustment expenses | $124.3m | $162.2m | $172.7m | $467.9m | $536.5m | — | |
| Deferred ceding commission | ($5.2m) | ($651k) | $7.2m | $3.4m | $6.0m | — | |
| Funds held for others | $2.6m | $7.3m | $21.7m | $44.1m | $25.3m | — | |
| Other, net | $44k | $0 | ($5.0m) | ($12.8m) | ($28.0m) | — | |
| Purchase of fixed maturity securities, available-for-sale | ($255.2m) | ($268.8m) | ($459.7m) | ($617.6m) | ($910.0m) | — | |
| Purchase of equity securities | ($60.3m) | ($53.5m) | ($26.0m) | ($14.1m) | ($13.2m) | — | |
| Purchase of intangible assets and goodwill | — | — | ($50k) | $0 | ($2.0m) | — | |
| Investment in direct and indirect loans | — | ($9.8m) | $3.0m | $27.5m | $19.7m | — | |
| Proceeds from the sales of fixed maturity securities, available-for-sale | $135.3m | $95.6m | $127.2m | $217.5m | $198.2m | — | |
| Maturities, calls, transfers and paydowns of fixed maturity securities, available-for-sale | — | $44.5m | $49.0m | $122.7m | $184.0m | — | |
| Maturities, calls and paydowns of fixed maturity securities held-to-maturity | — | $0 | $11.4m | $6.0m | $4.4m | — | |
| Proceeds from the sales of equity securities | — | $37.2m | $40.2m | $37.5m | $126.7m | — | |
| Change in receivable/payable for securities | ($725k) | $529k | $76k | $34k | $11.9m | — | |
| Cash provided by deposit accounting | ($6.1m) | $3.2m | $11.9m | $4.0m | $3.3m | — | |
| Net cash used in investment activities | ($183.0m) | ($193.4m) | ($493.8m) | ($243.7m) | ($366.9m) | — | |
| Employee share purchases | $1.4m | $2.2m | $1.4m | $0 | $0 | — | |
| Repayment of stock notes receivable | — | $0 | $0 | $5.6m | $0 | — | |
| Proceeds from initial public offering | — | $0 | $129.6m | $0 | $0 | — | |
| Cash paid for interest | $4.7m | $5.8m | $10.7m | $8.6m | $6.1m | — |